IgA Type Multiple Myeloma, Clinical Features, and Prognosis

IgA Type Multiple Myeloma, Clinical Features, and Prognosis

Bibliographic Details
Main Authors:	Ling Wang, Feng-Yan Jin, Ying Li, Jing-Nan Sun, Jia-Jia Zhang, Ran Tang, Yu-Ping Zhong
Format:	Article
Language:	English
Published:	Wolters Kluwer 2018-01-01
Series:	Chinese Medical Journal
Online Access:	http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=10;spage=1249;epage=1250;aulast=Wang

Similar Items

Neuromeningeal cryptoccocosis revealing IgA-λ multiple myeloma
by: Latifa Mtibaa, et al.
Published: (2021-06-01)

Dexamethasone implant for immunogammopathy maculopathy associated with IgA multiple myeloma
by: Constantine D. Georgakopoulos, et al.
Published: (2019-01-01)

Crescentic Glomerulonephritis in IgA Multiple Myeloma: A Case Report
by: Grace T. Moscoso-Solorzano, et al.
Published: (2011-09-01)

IgA nephropathy in a patient with IgG myeloma
by: B Sangeeta Lakshmi, et al.
Published: (2018-01-01)

Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma
by: Yuki Kawata, et al.
Published: (2021-02-01)

Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01)

Clinicopathological Study of Primary IgA Nephropathy: Correlation of Pathologic Features with Prognosis
by: 賴銘淙

Clinicopathological study of primary IgA nephropathy: correlation of pathologic features with prognosis
by: LAI, MING-ZONG, et al.
Published: (1987)

Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy
by: Fang-Ying Xia, et al.
Published: (2019-01-01)

IgA in IgA nephropathy
by: Layward, Lorna
Published: (1992)

Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients
by: Adrien Bosseboeuf, et al.
Published: (2020-05-01)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
by: Youxia Liu, et al.
Published: (2019-01-01)

Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?
by: Øystein Sefland, et al.
Published: (2019-01-01)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
by: Manliu Wang, et al.
Published: (2020-02-01)

IgA glycosylation in IgA nephropathy
by: Allen, Alice
Published: (1995)

IgA Myeloma, Portal Hypertension and Normal Skeletal Survey—A Triad
by: Waseem Raja Dar
Published: (2015-01-01)

DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.
by: Qiang Sun, et al.
Published: (2015-01-01)

Abnormal Aspects of IgA in IgA Nephropathy
by: Akash Nabil, et al.
Published: (2000-01-01)

Serum EA-IgA and d-dimer, but not VCA-IgA, are associated with prognosis in patients with nasopharyngeal carcinoma: a meta-analysis
by: Tianhao Liang, et al.
Published: (2021-06-01)

IgA Myeloma and Still’s Disease in a patient with bilateral silicone breast implants
by: Yadav Punit, et al.
Published: (2008-06-01)

Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
by: Xing-Zi Liu, et al.
Published: (2020-01-01)

The role of filtered IgA in the progression of IgA nephropathy
by: Cheung, Chee Kay
Published: (2017)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

The Association between Serum Hemoglobin and Renal Prognosis of IgA Nephropathy
by: Tae Ryom Oh, et al.
Published: (2021-01-01)

Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy
by: Julia Neuhaus, et al.
Published: (2018-10-01)

The Effects of Hyperuricemia on the Prognosis of IgA Nephropathy are More Potent in Females
by: Tae Ryom Oh, et al.
Published: (2020-01-01)

Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney Allograft
by: Catherine R. Kavanagh, et al.
Published: (2021-09-01)

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
by: Kai Zhang, et al.
Published: (2019-10-01)

Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria
by: Ding Chen, et al.
Published: (2018-03-01)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
by: Qiang Sun, et al.
Published: (2016-01-01)

Increased frequency of suldace IgA-Positive Plasma cells in the intestinal lamina propria and decreased IgA excretion in hyper IgA(HIGA) mice, a murine model of IgA nephropathy with hyperserum IgA
by: Kamata, Tadashi
Published: (2011)

Clinicopathological Features and Outcomes of IgA Nephropathy with Hematuria and/or Minimal Proteinuria
by: Min Tan, et al.
Published: (2015-04-01)

A report on the syndrome of inappropriate anti-diuretic hormone secretion associated with multiple myeloma
by: Ran Tang, et al.
Published: (2020-06-01)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
by: Dita Maixnerova, et al.
Published: (2019-01-01)

Nefropatia por IgA nas espondiloartrites IgA nephropathy in spondyloarthritis
by: Daniela Castelo Azevedo, et al.
Published: (2011-02-01)

Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
by: Youxia Liu, et al.
Published: (2019-09-01)

Linear IgA disease in an adult with unusual clinical features
by: Rajesh Verma, et al.
Published: (2013-01-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
by: Dita Maixnerova, et al.
Published: (2019-01-01)

Generalized acquired cutis laxa and urticarial dermatoses associated with қ-chain IgA micromolecular myeloma
by: Gaia Moretta, et al.
Published: (2021-08-01)